Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets

References

• AlHusban F, Perrie Y, Mohammed AR. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets. Eur J Pharm Biopharm 2011;79:627–34.
   PubMed Web of Science ®Google Scholar
• Nagar P, Singh K, Chauhan I, et al. Orally disintegrating tablets: formulation, preparation techniques and evaluation. JAPS 2011;1:35–45.
   Google Scholar
• Debjit B, Chiranjib B, Jyoti J, et al. Fast dissolving tablets: a review on revolution of novel drug delivery system and new market opportunities. Der Pharmacia Lettre 2009;1:262–76.
   Google Scholar
• Abed KK, Hussein AA, Ghareeb MM, et al. Formulation and optimization of orodispersible tablets of diazepam. AAPS Pharmscitech 2010;11:356–61.
   PubMed Web of Science ®Google Scholar
• Montgomery W, Treuer T, Karagianis J, et al. Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties. Ppa 2012;6:109–25.
   Web of Science ®Google Scholar
• Mahajan H, Patel S, Makwana S, et al. Fast-disintegrating tablets of atenolol using spray dried excipient base: development and evaluation. Inventi Rapid: Pharm Tech 2010.
   Google Scholar
• Jagdale S, Hable A, Chabukswar A, et al. Improvement of dissolution rate of chlorzoxazone by solid dispersion technique and development of buccal patch. J Appl Sol Chem Model 2013;2:145.
   Google Scholar
• Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharmaceutics 2012;1–10. [Epub ahead of print]. doi: 10.5402/2012/195727.
   Google Scholar
• Raval MK, Patel JM, Parikh RK, et al. Dissolution enhancement of chlorzoxazone using cogrinding technique. Int J Pharm Investig 2015;5:247.
   PubMedGoogle Scholar
• Moqbel HA, ElMeshad AN, El-Nabarawi MA. A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation. Drug Deliv 2016;1–10. [Epub ahead of print]. doi: 10.3109/10717544.2016.1138340.
   PubMed Web of Science ®Google Scholar
• Tayel SA, EL-Nabarawi MA, Ameen MM. Pharmaceutical study on an antimigraine drug. Cairo: Cairo university; 2013.
   Google Scholar
• Spireas S, Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int J Pharm 1998;166:177–88.
   Web of Science ®Google Scholar
• Chella N, Shastri N, Tadikonda RR. Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan. Acta Pharm Sinic 2012;2:502–8.
   Google Scholar
• Spireas S, Bolton SM. Liquisolid systems and methods of preparing same. Google Patents 2000.
   Google Scholar
• Reddy S, Dondeti S, Manavalan R, et al. Palatability evaluation study of oral disintegrating tablets by human volunteers. Int J Pharma Sci Res 2010;1:326–46.
   Google Scholar
• European P. Published by the directorate for the quality of medicines of the council of Europe 9EDQM, Strasbourg, France. 2002.
   Google Scholar
• British P. Published by The Stationery Office onbehalf of the Medicines and Healthcare products Regulatory Agency (MHRA), London. 2013.
   Google Scholar
• Abd-El Bary A, Louis D, Sayed S. Liquisolid tablet formulation as a tool to improve the dissolution of olmesartan medoxomil. Inventi Rapid: NDDS 2014;3:1–8.
   Google Scholar
• Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2008;69:993–1003.
   PubMed Web of Science ®Google Scholar
• Banquy X. Formulation development and characterization of liquisolid tablets containing clozapine. Canada: Montreal university; 2014.
   Google Scholar
• British P. Published by The Stationery Office on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA), London. 2013.
   Google Scholar
• Stoltenberg I, Breitkreutz J. Orally disintegrating mini-tablets (ODMTs)-a novel solid oral dosage form for paediatric use. Eur J Pharm Biopharm 2011;78:462–9.
   PubMed Web of Science ®Google Scholar
• Caramella C, F F, Bonferoni MC, Ronchi M. Disintegrants in solid dosage forms. Drug Dev Ind Pharm 1990;16:2561–77.
   Web of Science ®Google Scholar
• Selkirk AB, Ganderton D. An investigation of the pore structure of tablets of sucrose and lactose by mercury porosimetry. J Pharm Pharmacol 1970;22:79S–85S.
   Web of Science ®Google Scholar
• Shu T, S H, Hironaka K, Ito K. Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Chem Pharm Bull 2002;50:193–8.
   PubMed Web of Science ®Google Scholar
• Gohel M, Patel M, Amin A, et al. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPs PharmSciTech 2004;5:10–15.
   Web of Science ®Google Scholar
• Zhao N, Augsburger LL. Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution. AAPS Pharmscitech 2005;6:E634–E40.
   PubMed Web of Science ®Google Scholar
• Spireas S, Wang T, Grover R. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts. Drug Dev Ind Pharm 1999;25:163–8.
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm Pharm Sci 2007;341:26–34.
   Web of Science ®Google Scholar
• Spireas S, Sadu S, Grover R. In vitro release evaluation of hydrocortisone liquisolid tablets. J Pharm Sci 1998;87:867–72.
   PubMed Web of Science ®Google Scholar
• Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen. Eur J Pharm Biopharm 2009;73:373–84.
   PubMed Web of Science ®Google Scholar
• McCauley JA, Brittain HG. Thermal methods of analysis, in physical characterization of pharmaceutical solids, drugs and pharmaceutical sciences. New York: Marcel Dekker Inc; 1995. 223–50.
   Google Scholar